Literature DB >> 20187865

Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Jens Watzlawik1, Arthur E Warrington, Moses Rodriguez.   

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the CNS. A better understanding of why remyelination fails in MS is necessary to improve remyelination strategies. Remyelination is mediated by oligodendrocyte precursor cells (OPCs), which are widely distributed throughout the adult CNS. However, it is still unclear whether OPCs detectable in MS lesions survive the inflammatory response but are unable to myelinate or whether OPC and oligodendrocyte death is primarily responsible for remyelination failure and detectable OPCs enter demyelinated areas from adjacent tissue as the lesion evolves. Remyelination strategies should, therefore, focus on stimulation of differentiation or prevention of apoptosis, as well as establishment of a supportive environment for OPC-mediated remyelination, which may be especially important in chronically demyelinated lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187865      PMCID: PMC2842090          DOI: 10.1586/ern.10.13

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  288 in total

1.  Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination.

Authors:  S Hisahara; T Araki; F Sugiyama; K i Yagami; M Suzuki; K Abe; K Yamamura; J Miyazaki; T Momoi; T Saruta; C C Bernard; H Okano; M Miura
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

2.  Decline in rate of colonization of oligodendrocyte progenitor cell (OPC)-depleted tissue by adult OPCs with age.

Authors:  D M Chari; A J Crang; W F Blakemore
Journal:  J Neuropathol Exp Neurol       Date:  2003-09       Impact factor: 3.685

3.  NGF regulates the expression of axonal LINGO-1 to inhibit oligodendrocyte differentiation and myelination.

Authors:  Xinhua Lee; Zhongshu Yang; Zhaohui Shao; Sheila S Rosenberg; Melissa Levesque; R Blake Pepinsky; Mengsheng Qiu; Robert H Miller; Jonah R Chan; Sha Mi
Journal:  J Neurosci       Date:  2007-01-03       Impact factor: 6.167

4.  FGF modulates the PDGF-driven pathway of oligodendrocyte development.

Authors:  R D McKinnon; T Matsui; M Dubois-Dalcq; S A Aaronson
Journal:  Neuron       Date:  1990-11       Impact factor: 17.173

5.  Interactions between nitric oxide, oxygen, reactive oxygen species and reactive nitrogen species.

Authors:  G C Brown; V Borutaite
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

6.  Tumour necrosis factor-induced death of adult human oligodendrocytes is mediated by apoptosis inducing factor.

Authors:  Anna Jurewicz; Mariola Matysiak; Krzysztof Tybor; Lukasz Kilianek; Cedric S Raine; Krzysztof Selmaj
Journal:  Brain       Date:  2005-10-11       Impact factor: 13.501

7.  Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

Authors:  N Mohan; E T Edwards; T R Cupps; P J Oliverio; G Sandberg; H Crayton; J R Richert; J N Siegel
Journal:  Arthritis Rheum       Date:  2001-12

8.  Insulin-like growth factor (IGF) signaling through type 1 IGF receptor plays an important role in remyelination.

Authors:  Jeffrey L Mason; Shouhong Xuan; Ioannis Dragatsis; Argiris Efstratiadis; James E Goldman
Journal:  J Neurosci       Date:  2003-08-20       Impact factor: 6.167

Review 9.  Molecular mechanisms of axonal damage in inflammatory central nervous system diseases.

Authors:  Harald Neumann
Journal:  Curr Opin Neurol       Date:  2003-06       Impact factor: 5.710

10.  LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis.

Authors:  Sha Mi; Bing Hu; Kyungmin Hahm; Yi Luo; Edward Sai Kam Hui; Qiuju Yuan; Wai Man Wong; Li Wang; Huanxing Su; Tak-Ho Chu; Jiasong Guo; Wenming Zhang; Kwok-Fai So; Blake Pepinsky; Zhaohui Shao; Christilyn Graff; Ellen Garber; Vincent Jung; Ed Xuekui Wu; Wutian Wu
Journal:  Nat Med       Date:  2007-09-30       Impact factor: 53.440

View more
  15 in total

Review 1.  Neurovascular unit: a focus on pericytes.

Authors:  Inês Sá-Pereira; Dora Brites; Maria Alexandra Brito
Journal:  Mol Neurobiol       Date:  2012-02-28       Impact factor: 5.590

Review 2.  Translational research in neurology and neuroscience 2010: multiple sclerosis.

Authors:  Olaf Stüve; Bernd C Kieseier; Bernhard Hemmer; Hans-Peter Hartung; Amer Awad; Elliot M Frohman; Benjamin M Greenberg; Michael K Racke; Scott S Zamvil; J Theodore Phillips; Ralf Gold; Andrew Chan; Uwe Zettl; Ron Milo; Ellen Marder; Omar Khan; Todd N Eagar
Journal:  Arch Neurol       Date:  2010-07-12

3.  NF-κB Activation Protects Oligodendrocytes against Inflammation.

Authors:  Sarrabeth Stone; Stephanie Jamison; Yuan Yue; Wilaiwan Durose; Ruth Schmidt-Ullrich; Wensheng Lin
Journal:  J Neurosci       Date:  2017-08-23       Impact factor: 6.167

4.  Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis.

Authors:  Fucheng Luo; Karl Herrup; Xin Qi; Yan Yang
Journal:  Exp Neurol       Date:  2017-02-24       Impact factor: 5.330

5.  Ameliorating Effect of Osteopontin on H2O2-Induced Apoptosis of Human Oligodendrocyte Progenitor Cells.

Authors:  Neda Mazaheri; Maryam Peymani; Hamid Galehdari; Kamran Ghaedi; Ali Ghoochani; Abbas Kiani-Esfahani; Mohammad Hossein Nasr-Esfahani
Journal:  Cell Mol Neurobiol       Date:  2017-11-06       Impact factor: 5.046

6.  The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3β and deregulation of molecular motors.

Authors:  Ludovico Cantuti Castelvetri; Maria I Givogri; Amy Hebert; Benjamin Smith; Yuyu Song; Agnieszka Kaminska; Aurora Lopez-Rosas; Gerardo Morfini; Gustavo Pigino; Mark Sands; Scott T Brady; Ernesto R Bongarzone
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

Review 7.  Oligodendroglia-lineage cells in brain plasticity, homeostasis and psychiatric disorders.

Authors:  F Birey; A G Kokkosis; A Aguirre
Journal:  Curr Opin Neurobiol       Date:  2017-10-23       Impact factor: 6.627

8.  Immunity and inflammation in neurodegenerative diseases.

Authors:  Giuseppe Cappellano; Miryam Carecchio; Thomas Fleetwood; Luca Magistrelli; Roberto Cantello; Umberto Dianzani; Cristoforo Comi
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

9.  Minocycline plus N-acetylcysteine protect oligodendrocytes when first dosed 12 hours after closed head injury in mice.

Authors:  Michael Sangobowale; Elena Nikulina; Peter J Bergold
Journal:  Neurosci Lett       Date:  2018-06-06       Impact factor: 3.046

10.  MicroRNAs and Multiple Sclerosis.

Authors:  Kemal Ugur Tufekci; Meryem Gulfem Oner; Sermin Genc; Kursad Genc
Journal:  Autoimmune Dis       Date:  2010-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.